Abstract
It is not clear if hereditary site-specific ovarian cancer exists as a genetic entity distinct from the hereditary breast-ovarian cancer syndrome. We have identified a large Ashkenazi Jewish kindred with 8 cases of ovarian carcinoma and no cases of breast cancer. Initially, linkage analysis for this kindred generated a negative LOD score to BRCA1, but subsequent mutation and haplotype analysis of key individuals demonstrated a BRCA1 185delAG mutation segregating with all but 1 of the ovarian cancer cases. This observation has important implications for genetic counselling of families with site-specific ovarian cancer. hereditary site-specific ovarian cancer is likely to be a variant of the hereditary breast-ovarian cancer syndrome, attributable to either BRCA1 or BRCA2. We consider women from these families to be at increased risk of breast cancer and counsel them accordingly.
Original language | English |
---|---|
Pages (from-to) | 55-58 |
Number of pages | 4 |
Journal | American Journal of Medical Genetics |
Volume | 75 |
Issue number | 1 |
DOIs | |
State | Published - Jan 6 1998 |
Keywords
- BRCA1 Protein/biosynthesis
- Breast Neoplasms/genetics
- Canada/ethnology
- Carcinoma/genetics
- Disease Susceptibility
- Female
- Gene Expression Regulation, Neoplastic
- Genotype
- Germ-Line Mutation
- Humans
- Jews/genetics
- Middle Aged
- Ovarian Neoplasms/genetics
- Pedigree
- Phenotype
- Syndrome